Skip to main content
FinSpry Logo
FinSpry
CYCN logo
CYCN
(NASDAQ)
Cyclerion Therapeutics, Inc.
$6.38-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Cyclerion Therapeutics (CYCN) Stock Price & Financial Analysis

Cyclerion Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.37 - $8.48
52-Week High$8.48
52-Week Low$1.03
Open$5.42
Volume256.34M
Average Volume (3M)256.34M
Market Cap20.58M
Shares Outstanding3.23M
Price to Sales (P/S)7.21
Price to Book (P/B)2.16
EV/EBITDA-4.41
Revenue (TTM)2.85M
Net Income (TTM)-2.20M
EPS (TTM)$-0.68
Profit Margin-77.02%
Operating Margin-127.25%
Return on Equity (ROE)-23.06%
Debt to Equity0.00
50-Day MA$1.49
200-Day MA$2.06
52-Week Change151.18%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cyclerion Therapeutics

What is the current stock price for CYCN?

As of the latest trading session, CYCN stock trades at $6.38. The 52-week range is $1.03–$8.48, with a day range of $5.37–$8.48.

What is the P/E ratio for CYCN?

The P/E ratio (Price-to-Earnings) for CYCN is shown in the Key Statistics section. This valuation metric helps compare Cyclerion Therapeutics, Inc. to industry peers.

Does CYCN pay dividends?

Cyclerion Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CYCN?

Analyst ratings and recommendations for CYCN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CYCN?

Cyclerion Therapeutics's market capitalization is $20.6M, classifying it as a micro-cap company. Cyclerion Therapeutics operates in the Healthcare sector within the Biotechnology industry.